Correlation Between Annexon and CytomX Therapeutics

Can any of the company-specific risk be diversified away by investing in both Annexon and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Annexon and CytomX Therapeutics, you can compare the effects of market volatilities on Annexon and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and CytomX Therapeutics.

Diversification Opportunities for Annexon and CytomX Therapeutics

0.7

Correlation Coefficient

Annexon  CytomX Therapeutics

Poor diversification

The 3 months correlation between Annexon and CytomX is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Annexon i.e., Annexon and CytomX Therapeutics go up and down completely randomly.

Pair Corralation between Annexon and CytomX Therapeutics

Given the investment horizon of 90 days Annexon is expected to generate 3.14 times less return on investment than CytomX Therapeutics. But when comparing it to its historical volatility, Annexon is 3.63 times less risky than CytomX Therapeutics. It trades about 0.16 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  97.00  in CytomX Therapeutics on May 6, 2025 and sell it today you would earn a total of  138.00  from holding CytomX Therapeutics or generate 142.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Annexon  vs.  CytomX Therapeutics

Annexon

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Annexon are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Annexon showed solid returns over the last few months and may actually be approaching a breakup point.

CytomX Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CytomX Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, CytomX Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Annexon and CytomX Therapeutics

The main advantage of trading using opposite Annexon and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.

The idea behind Annexon and CytomX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.